Diskussionsleitung: U. Hofmann (Würzburg), S. Pankuweit (Marburg)
| (P526) | Interleukin-17 and Interferon-Gamma in patients with different forms of non-ischemic cardiomyopathies | |
| V. Zach, C. Plappert, G. Aleshcheva, C. Baumeier, H.-P. Schultheiss, F. Escher (Berlin) | ||
| (P527) | Inflammatory MiRNAs of the heart | |
| G. Aleshcheva, C. Baumeier, F. Escher, H.-P. Schultheiss (Berlin) | ||
| (P528) | Circulating MMP-1 and PICP levels discriminate infarct-like myocarditis and non-ST-elevation myocardial infarction | |
| L. Bacmeister, E. Cavus, S. Bohnen, E. Tahir, T. Zeller, F. Ojeda, U. K. Radunski, G. Lund, G. Adam, S. Blankenberg, D. Westermann, K. Müllerleile, D. Lindner (Freiburg im Breisgau, Hamburg, Elmshorn) | ||
| (P529) | GPR15-mediated T cell recruitment during acute viral myocarditis facilitated virus elimination and improved outcome | |
| D. Lindner, B. Stoffers, L. Bacmeister, H. Bräuninger, S. Warnke, M. Brehm, P. M. Becher, F. Escher, K. Klingel, P. Kirchhof, S. Blankenberg, T. Zeller, D. Westermann (Freiburg im Breisgau, Hamburg, Siegen, Berlin, Tübingen) | ||
| (P530) | MCMV infection triggers cardiac dysfunction in a Pkp2+/- but not in a Ttn+/- knockout model by worsening inflammatory responses | |
| A. Cirnu, T. Williams, M. Nörpel, J. Kammerer, A.-P. Arias-Loza, M. Lhoda, D. Ashour, G. Ramos, L. Dölken, C. Cochain, B. Gerull, für die Studiengruppe: DZHI (Würzburg) | ||
| (P531) | Gezieltes Next-Generation-Sequencing aus Endomyokardbiopsien in der Diagnose von transkriptionell aktiven B19V- und EBV-Infektionen | |
| C. Baumeier, D. Harms, B. Altmann, G. Aleshcheva, C.-T. Bock, F. Escher, H.-P. Schultheiss (Berlin) | ||
| (P532) | Endomyocardial protein and gene expression of pro-inflammatory and pro-fibrotic biomarkers are associated with clinical outcome in patients with non-ischemic cardiomyopathy | |
| K.-P. Kreisselmeier, T. Harm, I. I. Müller, K. Klingel, O. Borst, D. Heinzmann, J. Schreieck, T. Geisler, M. Gawaz, K. A. L. Müller (Tübingen) | ||
| (P533) | Nachweis kardiotroper Viren in Endomyokardbiopsien durch gezieltes NGS |
|
| C. Baumeier, D. Harms, B. Altmann, G. Aleshcheva, C.-T. Bock, F. Escher, H.-P. Schultheiss (Berlin) |